Imipramine Pamoate
Active substance: imipramine pamoate
CAPSULE · IMIPRAMINE PAMOATE 150 mg/1
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- IMIPRAMINE PAMOATE · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-a5c7-7bf7-b8f9-83a16ca9c59d,01a1208d-8c9c-7c72-beea-642eaf53308f,01a1208e-c11a-74a6-8562-5aef74d4f107,01a12090-9a68-7133-bab3-01f2bd06e4a5,01a12092-5f75-7962-8bf4-836042b653c4;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0054-0276
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0054-0276 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0054-0276 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0054-0276 · Verified 2026-10-09 · open in source